Hormone linked to sugar control in diabetics
|
|
High blood levels of a hormone called adiponectin are associated with improved sugar control in women with Diabetes Mellitus, new research shows.
In addition, high adiponectin levels are associated with high levels of HDL “good” cholesterol and with reduced inflammation. Taken together, these effects could help reduce the risk of Heart Disease and Stroke.
Previous reports have suggested that low adiponectin levels may raise the risk of plaque build-up, or “Atherosclerosis,” in diabetics. However, the complex interplay between adiponectin levels and various metabolic parameters has not been fully investigated.
Dr. Christos S. Mantzoros, from the Harvard Medical School in Boston, and colleagues assessed the association between adiponectin levels and sugar control, cholesterol and inflammation in 925 diabetic women enrolled in the Nurses’ Health Study.
The researchers’ findings appear in the Journal of Clinical Endocrinology and Metabolism.
Adiponectin levels increased as HDL cholesterol levels and physical activity levels rose. By contrast, adiponectin levels dropped as body weight, LDL “bad” cholesterol and various inflammatory proteins increased.
An LDL test measures the level of low-density lipoprotein, or LDL, in the blood. LDL is also called the bad carrier for cholesterol. Cholesterol is a waxy substance that is used for many body processes.
The LDL test is usually done as part of a lipid profile test that also includes total cholesterol, HDL test, and triglycerides.
Overall, the results suggest that adiponectin has direct beneficial effects in preventing atherosclerosis, the authors conclude.
SOURCE: Journal of Clinical Endocrinology and Metabolism, August 2005.
Print Version
Tell-a-Friend comments powered by Disqus
